$NTRR Washington State Faces First Cannabis Product Recall

Need continues to build across the U.S. cannabis industry for all-natural pesticide alternatives such as those being marketed by Neutra Corp. (NTRR). This week, Washington State faced its very first cannabis product recall due to concerns over illegal pesticide usage.

A Washington-based cannabis wholesaler issued the voluntary recall after two cannabis producers used by the wholesaler were recently investigated by the state’s Liquor and Cannabis Board (LCB) for the use of prohibited pesticides. The three products facing recalls are all high-CBD edibles, which constitute a popular and growing segment of the U.S. cannabis industry. While Colorado’s cannabis market has weathered several product recalls in recent years, this was the first in Washington State, where voters legalized cannabis for adult use in 2012.

Health concerns have increasingly threatened to derail profits in the U.S. cannabis industry, creating a new market opportunity for companies such as NTRR. Many pest-control products used in agriculture have not been approved for products intended to be consumed or smoked, and public fears about these harsh chemicals have led to increasing scrutiny and regulation. NTRR is working to help the industry sidestep the problem by offering up alternatives.

NTRR is marketing new, potentially healthier alternatives to harsh chemicals in cannabis cultivation. Alongside joint venture partner Surface to Air Solutions (S2O2), the company offers cannabis growers and other businesses a suite of horticultural products—including a plant stimulant, an air-scrubber and a self-cleaning hard surface treatment. Used together, the suite of products helps allow healthy plants to thrive without the use of pesticides and fungicides. Some are already in use by growers in the United States and Canada.

For more information, please visit https://www.neutracorp.com/investors.html.

About Neutra Corp.

As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how they grow, what they grow, and how they consume cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, NTRR is constantly combing the industry for the latest and greatest to test, prove and bring to market.

By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPH), Cara Therapeutics Inc. (CARA) and 22nd Century Group, Inc. (XXII). For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

View source version on businesswire.com:https://www.businesswire.com/news/home/20160218005586/en/